USEUROPEAFRICAASIA 中文双语Français
Home / Business

Chinese vaccine maker to raise $141.3m from STAR Market

By Liu Zhihua | China Daily | Updated: 2019-10-16 08:16

CanSino Biologics Inc, the Chinese mainland's first vaccine maker listed in Hong Kong, plans to file for a listing on Shanghai's tech-focused STAR Market, or the sci-tech innovation board, in the hope of raising about 1 billion yuan ($141.33 million).

The biotech company announced on Monday that it planned to issue up to 24.8 million shares in the Shanghai offering, and the money raised would be used for constructing its production base, boosting vaccine research and development, cold chain logistics, and information system construction, among others.

Following the announcement, the company's share price soared by 14.57 percent during trading before closing 8.14 percent higher on Monday at HK$37.85 ($4.83).

Chinese vaccine maker to raise $141.3m from STAR Market

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US